Unknown

Dataset Information

Physical instability of a therapeutic Fc fusion protein: domain contributions to conformational and colloidal stability.


ABSTRACT: Protein therapeutics made up of artificially combined proteins or protein domains, so-called fusion proteins, are a novel and growing class of biopharmaceuticals. We have studied abatacept (Orencia), a fusion protein that is constructed of a modified IgG Fc domain and the soluble part of the T-cell receptor CTLA-4. In accelerated degradation studies conducted at 40 degrees C, a pH shift from 7.5 to 6.0 yields significantly faster aggregation kinetics, as measured by size-exclusion chromatography. To understand how the fusion domains and their interactions contribute to this result, we considered aggregation in light of the modified Lumry-Eyring reaction pathway. Protein conformational stabilities against chaotropes and temperature were measured. The structural consequences of these perturb

SUBMITTER: Fast JL 

PROVIDER: S-EPMC2835945 | biostudies-literature | 2009 Dec

REPOSITORIES: biostudies-literature